Pages that link to "Q34336896"
Jump to navigation
Jump to search
The following pages link to Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I. (Q34336896):
Displaying 50 items.
- Rhythmic binding of Topoisomerase I impacts on the transcription of Bmal1 and circadian period (Q24297026) (← links)
- SUMO-1 conjugation to topoisomerase I: A possible repair response to topoisomerase-mediated DNA damage (Q24682811) (← links)
- Inhibition of Human Immunodeficiency Virus (HTV-1) Replication In Vitro by Noncytotoxic Doses of Camptothecin, a Topoisomerase I Inhibitor (Q28323784) (← links)
- Topotecan inhibits human immunodeficiency virus type 1 infection through a topoisomerase-independent mechanism in a cell line with altered topoisomerase I (Q28378884) (← links)
- Biological Mechanism Profiling Using an Annotated Compound Library (Q33193573) (← links)
- Clinical studies of camptothecin and derivatives (Q33194418) (← links)
- Phase I-II study of irinotecan combined with mitomycin-C in patients with advanced gastric cancer (Q33341045) (← links)
- The bioavailability of oral GI147211 (GG211), a new topoisomerase I inhibitor (Q33500497) (← links)
- DNA topoisomerase-targeting antitumor drugs can be studied in yeast (Q33654182) (← links)
- Design, synthesis, and biological evaluation of O-2-modified indenoisoquinolines as dual topoisomerase I-tyrosyl-DNA phosphodiesterase I inhibitors (Q33662415) (← links)
- Human DNA topoisomerase I is encoded by a single-copy gene that maps to chromosome region 20q12-13.2. (Q33677099) (← links)
- Macrocyclic pyridyl polyoxazoles: selective RNA and DNA G-quadruplex ligands as antitumor agents (Q33833531) (← links)
- Peptide sequencing and site-directed mutagenesis identify tyrosine-727 as the active site tyrosine of Saccharomyces cerevisiae DNA topoisomerase I. (Q33856425) (← links)
- Topostin, a novel inhibitor of mammalian DNA topoisomerase I from Flexibacter topostinus sp. nov. II. Purification and some properties of topostin (Q33894566) (← links)
- Topoisomerase I activity associated with human immunodeficiency virus (HIV) particles and equine infectious anemia virus core. (Q33923420) (← links)
- The indenoisoquinoline noncamptothecin topoisomerase I inhibitors: update and perspectives (Q33925798) (← links)
- Identification of a topoisomerase I mutant, scsA1, as an extragenic suppressor of a mutation in scaA(NBS1), the apparent homolog of human nibrin in Aspergillus nidulans. (Q34617988) (← links)
- Transcription-dependent degradation of topoisomerase I-DNA covalent complexes (Q34784817) (← links)
- Characterization of an altered DNA catalysis of a camptothecin-resistant eukaryotic topoisomerase I. (Q34967081) (← links)
- Induction of cleavage in topoisomerase I c-DNA by topoisomerase I enzymes from calf thymus and wheat germ in the presence and absence of camptothecin (Q35020099) (← links)
- Topoisomerase I is preferentially associated with normal SV40 replicative intermediates, but is associated with both replicating and nonreplicating SV40 DNAs which are deficient in histones (Q35072982) (← links)
- A phase II trial of combination of CPT-11 and cisplatin for advanced non-small-cell lung cancer. CPT-11 Lung Cancer Study Group (Q36114656) (← links)
- In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabin (Q36116478) (← links)
- Reduced cellular accumulation of topotecan: a novel mechanism of resistance in a human ovarian cancer cell line (Q36292082) (← links)
- Low-level resistance to camptothecin in a human small-cell lung cancer cell line without reduction in DNA topoisomerase I or drug-induced cleavable complex formation (Q36293009) (← links)
- Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical development (Q36431807) (← links)
- Multi-Drug Resistance Genes in the Management of Neoplastic Disease (Q36529269) (← links)
- Resistance to inhibitors of DNA topoisomerases (Q36546741) (← links)
- Phase I/II study of weekly irinotecan and concurrent radiation therapy for locally advanced non-small cell lung cancer (Q36619185) (← links)
- Inhibition of retrovirus-induced disease in mice by camptothecin. (Q36648965) (← links)
- Cell cycle analysis of amount and distribution of nuclear DNA topoisomerase I as determined by fluorescence digital imaging microscopy (Q36703149) (← links)
- Camptothecin, a specific inhibitor of type I DNA topoisomerase, induces DNA breakage at replication forks (Q36792502) (← links)
- The topoisomerase I inhibitor, camptothecin, inhibits equine infectious anemia virus replication in chronically infected CF2Th cells (Q36797222) (← links)
- Topoisomerase I is preferentially associated with isolated replicating simian virus 40 molecules after treatment of infected cells with camptothecin (Q36872974) (← links)
- 11-Substituted 2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridine derivatives as novel topoisomerase I-targeting agents (Q37323423) (← links)
- Synthesis of N-substituted 5-[2-(N-alkylamino)ethyl]dibenzo[c,h][1,6]naphthyridines as novel topoisomerase I-targeting antitumor agents (Q37363590) (← links)
- 12-Substituted 2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridines as novel topoisomerase I-targeting antitumor agents (Q37363598) (← links)
- Novel topoisomerase I-targeting antitumor agents synthesized from the N,N,N-trimethylammonium derivative of ARC-111, 5H-2,3-dimethoxy-8,9-methylenedioxy-5-[(2-N,N,N-trimethylammonium)ethyl]dibenzo[c,h][1,6]naphthyridin-6-one iodide (Q37396799) (← links)
- New natural products in cancer chemotherapy (Q37608749) (← links)
- Macrocyclic pyridyl polyoxazoles: structure-activity studies of the aminoalkyl side-chain on G-quadruplex stabilization and cytotoxic activity. (Q37630342) (← links)
- Topoisomerases, new targets in cancer chemotherapy (Q37877829) (← links)
- A functional linker in human topoisomerase I is required for maximum sensitivity to camptothecin in a DNA relaxation assay (Q38318734) (← links)
- Identification of topoisomerase I mutations affecting both DNA cleavage and interaction with camptothecin (Q38350593) (← links)
- Biochemical changes in testicular varicocele (Q38666261) (← links)
- Structural and functional interactions of the prostate cancer suppressor protein NKX3.1 with topoisomerase I. (Q39171279) (← links)
- Topoisomerase I inhibitors and drug resistance (Q40028536) (← links)
- Effects of drug efflux proteins and topoisomerase I mutations on the camptothecin analogue gimatecan (Q40066258) (← links)
- Camptothecin enhances the frequency of oligonucleotide-directed gene repair in mammalian cells by inducing DNA damage and activating homologous recombination (Q40156233) (← links)
- Role of the linker domain and the 203-214 N-terminal residues in the human topoisomerase I DNA complex dynamics. (Q40308617) (← links)
- Comparison of effects of fostriecin, novobiocin, and camptothecin, inhibitors of DNA topoisomerases, on DNA replication and repair in human cells (Q40514331) (← links)